Anesthetic Considerations for a Novel Method of Surgical Ventricular Remodeling Using the BioVentrix Revivent TC System

Published:February 05, 2021DOI:
      Surgical ventricular remodeling (SVR) is an invasive method of treating patients with heart failure who also have ischemic cardiomyopathy and reduced ejection fraction (EF). Introduced in the mid-1980s, this technique was met with varying success and relatively high morbidity and mortality despite its theoretical benefits. The development of the BioVentrix Revivent TC System (BioVentrix, Inc., San Ramon, CA) as a less-invasive method of surgical ventricular remodeling has created a novel, multidisciplinary approach to heart failure management, which necessitates multiple subspecialties. Currently in the trial phase in the United States and widely used in Europe, the positive results to date appear promising for the rapid adoption of this procedure. For the cardiac anesthesiologist, a thorough understanding of the patient population, procedural goals, and intraoperative management is essential. This overview discusses the advancement in surgical ventricular remodeling, the pertinent surgical steps of the BioVentrix Revivent TC System placement, and specific anesthetic considerations for this novel procedure.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Howlett JG
        • Stebbins A
        • Petrie MC
        • et al.
        CABG improves outcomes in patients with ischemic cardiomyopathy: 10-year follow-up of the STICH trial.
        JACC Heart Fail. 2019; 7: 878-887
        • Petrie MC
        • Jhund PS
        • She L
        • et al.
        Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: An analysis of the extended follow-up of the STICH trial (Surgical Treatment for Ischemic Heart Failure).
        Circulation. 2016; 134: 1314-1324
        • Conte JV.
        Surgical ventricular restoration: Technique and outcomes.
        Congest Heart Fail. 2004; 10: 248-251
        • Ahuja K
        • Crooke GA
        • Grossi EA
        • et al.
        Reversing left ventricular remodeling in chronic heart failure: Surgical approaches.
        Cardiol Rev. 2007; 15: 184-190
        • Alfieri O
        • Maisano F
        • Schreuder JJ.
        Surgical methods to reverse left ventricular remodeling in congestive heart failure.
        Am J Cardiol. 2003; 91: 81F-87F
        • Athanasuleas CL
        • Stanley AW
        • Buckberg GD.
        Restoration of contractile function in the enlarged left ventricle by exclusion of remodeled akinetic anterior segment: Surgical strategy, myocardial protection, and angiographic results.
        J Card Surg. 1998; 13: 418-428
        • Athanasuleas CL
        • Stanley AW
        • Buckberg GD
        • et al.
        Surgical anterior ventricular endocardial restoration (SAVER) for dilated ischemic cardiomyopathy.
        Semin Thorac Cardiovasc Surg. 2001; 13: 448-458
        • Athanasuleas CL
        • Stanley AW
        • Buckberg GD
        • et al.
        Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction.
        J Am Coll Cardiol. 2001; 37: 1199-1209
        • Buckberg GD.
        Ventricular restoration—a surgical approach to reverse ventricular remodeling.
        Heart Fail Rev. 2004; 9 (discussion 347-51): 233-239
        • Hassanabad AF
        • MacQueen KT
        • Ali I
        Surgical Treatment for Ischemic Heart Failure (STICH) trial: A review of outcomes.
        J Card Surg. 2019; 34: 1075-1082
        • Michler RE
        • Rouleau JL
        • Al-Khalidi HR
        • et al.
        Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction.
        J Thorac Cardiovasc Surg. 2013; 146 (1139-45.e1136)
        • Isomura T
        • Hoshino J
        • Fukada Y
        • et al.
        Volume reduction rate by surgical ventricular restoration determines late outcome in ischaemic cardiomyopathy.
        Eur J Heart Fail. 2011; 13: 423-431
        • Klein P
        • Anker SD
        • Wechsler A
        • et al.
        Less invasive ventricular reconstruction for ischaemic heart failure.
        Eur J Heart Fail. 2019; 21: 1638-1650
        • Ruzza A
        • Czer LSC
        • Arabia F
        • et al.
        Left ventricular reconstruction for postinfarction left ventricular aneurysm: Review of surgical techniques.
        Tex Heart Inst J. 2017; 44: 326-335
        • Chiariello GA
        • Nesta M
        • Bruno P
        • et al.
        Total surgical plication of left ventricular aneurysm using the BioVentrix Revivent myocardial anchoring system.
        Innovations (Phila). 2019; 14: 369-373
        • Hennig F
        • Klein C
        • Knosalla C
        • et al.
        Minimally invasive left ventricular reconstruction of a postinfarction, anterior left ventricular scar (BioVentrix Revivent TC procedure).
        Multimed Man Cardiothorac Surg. 2020; 2020
        • Loforte A
        • Alfonsi J
        • Gliozzi G
        • et al.
        Less invasive ventricular enhancement (LIVE) as potential therapy for ischaemic cardiomyopathy end-stage heart failure.
        J Thorac Dis. 2019; 11: S921-S928
        • Klein P
        • Agostoni P
        • van Boven WJ
        • et al.
        Transcatheter and minimally invasive surgical left ventricular reconstruction for the treatment of ischaemic cardiomyopathy: Preliminary results.
        Interact Cardiovasc Thorac Surg. 2019; 28: 441-446
        • Klein P
        • Van Kuijk J
        • Swaans M.
        Hybrid transcatheter and minimally invasive left ventricular reconstruction for the treatment of ischemic cardiomyopathy: Mid-term results. Presented at: ESC Congress 2020 The Digital Experience. August 30, 2020
        • Adhikary SD
        • Pruett A
        • Forero M
        • et al.
        Erector spinae plane block as an alternative to epidural analgesia for post-operative analgesia following video-assisted thoracoscopic surgery: A case study and a literature review on the spread of local anaesthetic in the erector spinae plane.
        Indian J Anaesth. 2018; 62: 75-78
        • Forero M
        • Rajarathinam M
        • Adhikary S
        • et al.
        Continuous erector spinae plane block for rescue analgesia in thoracotomy after epidural failure: A case report.
        A A Case Rep. 2017; 8: 254-256
        • Reyad RM
        • Shaker EH
        • Ghobrial HZ
        • et al.
        The impact of ultrasound-guided continuous serratus anterior plane block versus intravenous patient-controlled analgesia on the incidence and severity of post-thoracotomy pain syndrome: A randomized, controlled study.
        Eur J Pain. 2020; 24: 159-170
        • Grosen K
        • Drewes AM
        • Højsgaard A
        • et al.
        Perioperative gabapentin for the prevention of persistent pain after thoracotomy: a randomized controlled trial.
        Eur J Cardiothorac Surg. 2014; 46: 76-85
        • Kinney MA
        • Mantilla CB
        • Carns PE
        • et al.
        Preoperative gabapentin for acute post-thoracotomy analgesia: A randomized, double-blinded, active placebo-controlled study.
        Pain Pract. 2012; 12: 175-183
        • de Medicis E.
        Gabapentin and post-thoracotomy shoulder pain.
        Can J Anaesth. 2008; 55 (author reply 879): 878-879